TG Therapeutics, Inc. (TGTX)
30.57
-0.14
(-0.46%)
USD |
NASDAQ |
Jan 16, 16:00
30.80
+0.23
(+0.75%)
After-Hours: 20:00
TG Therapeutics Market Cap: 4.853B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.421B |
| MannKind Corp. | 1.600B |
| Karyopharm Therapeutics, Inc. | 107.59M |
| Axsome Therapeutics, Inc. | 8.937B |
| Krystal Biotech, Inc. | 8.265B |
Market Cap Related Metrics
| PE Ratio | 11.00 |
| PS Ratio | 9.290 |
| Price to Book Value | 7.993 |
| Price | 30.57 |
| Earnings Yield | 9.09% |
| Operating PE Ratio | 48.08 |
| Normalized PE Ratio | 11.00 |